Howard Weintraub, MD

  • Specialties: Cardiology, Preventive Cardiology
  • Language: English
  • Phone: 212-263-0855

About Me

Conditions and Treatments

atherosclerosis, high cholesterol level, lipid disorders, lipid metabolism, high blood pressure disorder, prediabetes, metabolic syndrome, coronary heart disease, type 2 diabetes mellitus, chest pain, fainting, arteriosclerosis, obesity, heart throbbing, aortic valve disease, congestive heart failure (CHF), heart murmur, heart valve diseases, abnormal heart rhythms, mitral valve prolapse (MVP), rapid heartbeat, slow heartbeat, myocarditis, pulmonary hypertension, arteriosclerosis, inflammation of the heart valve, peripheral vascular disease (PVD), dilated cardiomyopathy, vascular disease occlusive, angina, heart disease, chronic venous insufficiency, heart failure, ventricular tachycardia (V-tach), sarcoidosis, arterial occlusive disease, atrioventricular septal defect, claudication, myocardial disease, mitral valve stenosis, endothelial dysfunction, rheumatic heart disease, cerebrovascular disorder, acute coronary syndrome, renal artery stenosis, atrial septal defect (ASD), aortic valve stenosis, heart attack, heart muscle disease, atrial fibrillation, carotid stenosis, ischemic cardiomyopathy, an inflammation of the membrane surrounding the heart, peripheral vascular disease (PVD), mitral valve disease, aortic valve insufficiency, cardiac disease in pregnancy, carotid artery disease, ventricular fibrillation, mitral regurgitation (MR), heart tumor, ventricular arrhythmia, renovascular, ventricular septal defect (VSD)
Show More Conditions

Credentials

Positions
  • Clinical Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Cardiovascular Disease), 1985
  • American Board of Internal Medicine - Internal Medicine, 1979
Education and Training
  • Fellowship, NYU Medical Center, Cardiology, 1982
  • Fellowship, NYU Medical Center, Pulmonary Diseases, 1980
  • Residency, NYU Medical Center, Medicine, 1979
  • MD from New York University, 1976
Departments

Locations and Appointments

42 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • HealthSmart (WTC)
  • Healthfirst
  • Humana Medicare
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYULMC Center for the Prevention of Cardiovascular Disease

530 1st Avenue, HCC, Suite 4F
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We are involved in an exciting trial of a new class of medication to lower her LDL cholesterol. The patients who are being studied are those who had an acute coronary syndrome within the last year. this study we'll be looking at the effect of significant lowering of LDL cholesterol on cardiovascular events.

We are also involved in a study of omega-3 fatty acids in the reduction of cardiovascular events.

We are also investigating the cardiac effects of a new drug to treat type II diabetes.

The Center for Prevention of Cardiovascular Disease is also involved in a large trial that examines the effectiveness of different prevention modalities in patients with known coronary artery disease.

Publications

  • Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials

    Bangalore, Sripal; Fakheri, Robert; Toklu, Bora; Ogedegbe, Gbenga; Weintraub, Howard; Messerli, Franz H
    Mayo Clinic proceedings. 2016 Jan. 91 (1): 51-60

  • Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

    Balakrishnan, Revathi; Berger, Jeffrey S; Tully, Lisa; Vani, Anish; Shah, Binita; Burdowski, Joseph; Fisher, Edward; Schwartzbard, Arthur; Sedlis, Steven; Weintraub, Howard; Underberg, James A; Danoff, Ann; Slater, James A; Gianos, Eugenia
    Diabetes/metabolism research & reviews. 2015 Feb. 603-609

  • Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)" [Letter]

    Doran, Bethany; Guo, Yu; Xu, Jinfeng; Weintraub, Howard; Mora, Samia; Maron, David J; Bangalore, Sripal
    Circulation. 2015 May. 131 (19): e473-e473 e473

Read All Publications (42)